Posted by & filed under International Business, Management, Organizational Behavior.

Description:  When Hal Dvorak, a Harvard scientist whose ideas helped spur the advance of targeted cancer drugs, sought a partner recently to help him develop new treatments, he only had to walk two blocks to find one.

Source: Bloomberg.com

Date: June 15, 2012

Link: http://www.bloomberg.com/news/2012-06-15/pfizer-sees-harvard-collaboration-as-spark-for-new-drugs.html

Questions for Discussions:

  • Describe the relationships between educational institutions and R&D departments of firms.
  • What drives these collaborative relations?
  • Is it a good idea, in your opinion?
  • Are there any drawbacks?

 

Leave a Reply

Your email address will not be published.